Supplement Figure 2 from First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies
Authors:
- A. Dimitrios ColevasACA. Dimitrios Colevas
- Zahra TalebiZTZahra Talebi
- Elizabeth WintersEWElizabeth Winters
- Caroline EvenCECaroline Even
- Victor Ho-Fun LeeVLVictor Ho-Fun Lee
- Maura L. GillisonMGMaura L. Gillison
- Saad A. KhanSKSaad A. Khan
- Rong LuRLRong Lu
- Benjamin A. PinskyBPBenjamin A. Pinsky
- Samantha S. SoldanSSSamantha S. Soldan
- Olga VladmirovaOVOlga Vladmirova
- Paul M. LiebermanPLPaul M. Lieberman
Open Access
- 3 March 2025
- other
- Published by American Association for Cancer Research (AACR)